Last updated: April 10, 2024
Sponsor: San Francisco Veterans Affairs Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Pain (Pediatric)
Mild Cognitive Impairment
Treatment
cross-sectional MRI and EEG assessments (NO INTERVENTION)
Clinical Study ID
NCT06208943
CX002322
Ages 18-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Our studies require some in-person visits to our research lab, located at 42nd Ave andClement St in San Francisco.
- Because this study includes an MRI, part of the screening process will be to ensureyou don't have any metal in your body, you do not have head or neck tattoos, and youare comfortable inside the MRI scanner.
- 18-70 years with a confirmed COVID infection at least 3 months ago.
- Negative metal screen for MRI safety
- Normal (or corrected to normal) vision
Exclusion
Exclusion Criteria:
- Past or present neurological problems (including seizures and head trauma resulting inneurological or cognitive symptoms)
- Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologicsymptoms
- Major medical conditions (e.g., seizures disorders, treatment with anticonvulsantmedication, endocrine disorders, significant cardiac pathology)
- Substance dependence, within the past year, or failed urine toxicology on the day ofneuroimaging sessions
- Known claustrophobia
- Current pregnancy
- IQ estimate < 70
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: cross-sectional MRI and EEG assessments (NO INTERVENTION)
Phase:
Study Start date:
October 01, 2021
Estimated Completion Date:
September 30, 2025
Study Description
Connect with a study center
San Francisco Heathcare System
San Francisco, California 94121
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.